News & Events
For media inquiries email [email protected]
Company news
October 24, 2025
Press Release
Parabilis Medicines Presents Clinical and Preclinical Data Demonstrating Broad Potential of Helicon™ Peptides at AACR-NCI-EORTC 2025
October 17, 2025
Press Release
Parabilis Medicines Presents Clinical Data Demonstrating First-Ever Drugging of Key Cancer Driver with FOG-001
September 3, 2025
Press Release
Parabilis Medicines Appoints Fawzi Benzaghou, M.D., as Chief Medical Officer
Publications and presentations
October 25, 2025
AACR-NCI-EORTC
Distinct aspects of β-catenin biology drive multiple biologically rational FOG-001 combinations for MSS colorectal cancer
Recent highlights
May 2, 2025
Podcast
“Therapeutic Momentum” Interview with Mathai Mammen
Parabilis CEO Mathai Mammen joined Karen Akinsanya, head of therapeutics R&D at Schrodinger, on the Therapeutic Momentum podcast for a wide-ranging discussion of science, leadership, purpose — and the very human motivations that fuel innovation.
Upcoming events
November 12, 2025
Boca Raton, FL